-
Recognized! Jafron as “National Intellectual Prope...2023-12-12 -
HA230 - Saving patients from acute poisoning and d...2023-12-07 -
2023 International Hemoadsorption Summit drew to a...2023-11-15 -
2023 International Hemoadsorption Summit was succe...2023-11-14 -
DPMAS - A Comprehensive Therapy for Liver Failure2023-08-01 -
Jafron was authorized to establish Guangdong Engin...2023-06-30 -
The "2nd European Course on Adsorption" ...2023-05-18 -
Annual Report 2022: Time to move to the next stage2023-05-09 -
HA130- Improve the quality of life for dialysis pa...2023-03-23
-
Recognized! Jafron as “National Intellectual Property Demonstration Enterprise”2023-12-12
-
HA230 - Saving patients from acute poisoning and drug overdose2023-12-07
-
2023 International Hemoadsorption Summit drew to a successful close2023-11-15
-
2023 International Hemoadsorption Summit was successfully concluded.2023-11-14
-
DPMAS - A Comprehensive Therapy for Liver Failure2023-08-01
-
Jafron was authorized to establish Guangdong Engineering Research Center of Bloo...2023-06-30
-
The "2nd European Course on Adsorption" was successfully held in Berga...2023-05-18
-
Annual Report 2022: Time to move to the next stage2023-05-09
-
HA130- Improve the quality of life for dialysis patients2023-03-23
Jafron Biomedical Co., Ltd.
Dirección: No. 98 Technology Six Road, High-tech Zone, Zhuhai City, China
Correo electrónico: customerservice@jafron.com
Sitio web: https://es.jafroninternational.com
Términos de uso｜Mapa del sitio｜ Aviso de cookies｜ Aviso de privacidad
Aviso de privacidad de la contratación
Línea directa disponible 24 horas al día, 7 días a la semana
© 2016 Jafron Biomedical Co., Ltd. Todos los derechos reservados.
